IBBQ ETF

IBBQ is a newer biotech ETF in the U.S. that competes with well-known funds like IBB and XBI, and it has done better than both since it started in June 2021. However, investors need to be aware of certain risks, including the unpredictable nature of the biotech sector, as well as IBBQ's liquidity, concentration, and quality aspects. Additionally, with just $38 million in assets and a 0.19% expense ratio, IBBQ may not be a profitable option for Invesco due to its high liquidation risk.

Following a multiyear run of disappointment, biotech stocks and related ETFs are showing signs of life. For the past 90 days ending February 29, the widely observed Nasdaq Biotechnology Index was higher by almost 17%.